A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis

Written by ClinicalTrials.gov

Category: Osteoarthritis

Published: 07 April 2011

Condition: Osteoarthritis, Knee
Interventions: Drug: JNJ-39439335; Drug: Placebo; Drug: JNJ-39439335; Drug: Naproxen
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified July 2011

Details: Last Updated: 07 April 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies